Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells

Lee-Hwa Tai1, Christiano Tanese de Souza, Simon Bélanger

  • 1Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Cancer Research
|October 24, 2012
PubMed

Insights

Surgical stress impairs natural killer (NK) cell function, increasing cancer metastasis. Perioperative treatments with oncolytic viruses can restore NK cell activity, reducing metastasis and improving survival in cancer patients.

Area of Science:

  • Immunology
  • Oncology
  • Surgical Science

Background:

  • Postoperative metastases are a significant concern in cancer surgery.
  • Natural killer (NK) cells are crucial for clearing tumor cells and preventing metastasis.
  • Surgical stress is suspected to impair NK cell function, but direct evidence is limited.

Purpose of the Study:

  • To investigate the impact of surgical stress on NK cell function and its role in postoperative metastasis.
  • To evaluate the efficacy of perioperative oncolytic viral therapy in restoring NK cell function and reducing metastasis.

Main Methods:

  • A mouse model of surgical stress was used to assess NK cell function and metastasis.
  • NK cells from surgically stressed mice were transferred to NK-deficient mice.
  • Tumor cell killing assays (ex vivo and in vivo) were performed.
  • Perioperative administration of oncolytic viruses (ORFV, vaccinia virus) was evaluated.
  • Human studies assessed NK cell cytotoxicity in postoperative cancer patients.

Main Results:

  • Surgical stress significantly reduced NK cell numbers, migration, and tumor cell killing capacity.
  • Surgically stressed mice exhibited enhanced lung metastases compared to controls.
  • Perioperative oncolytic virus administration reversed NK cell suppression and reduced metastasis.
  • Postoperative cancer patients showed reduced NK cell cytotoxicity.
  • Oncolytic vaccinia virus increased NK cell activity in cancer patients.

Conclusions:

  • Surgical stress impairs global NK cell function, contributing to postoperative cancer metastasis.
  • Perioperative oncolytic viral therapy represents a promising strategy to enhance NK cell activity.
  • Targeting NK cell function perioperatively may reduce metastatic recurrence and improve survival in cancer patients.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...